Lyerly, H. K., Hobeika, A., Niedzwiecki, D., Osada, T., Marshall, J., Garrett, C. R., … Morse, M. (2011). A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study. In Journal of Clinical Oncology (Vol. 29, pp. 2533–2533). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2011.29.15_suppl.2533

Lyerly, H. K., A. Hobeika, D. Niedzwiecki, T. Osada, J. Marshall, C. R. Garrett, D. Z. Chang, et al. “A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.” In Journal of Clinical Oncology, 29:2533–2533. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.2533.

Lyerly HK, Hobeika A, Niedzwiecki D, Osada T, Marshall J, Garrett CR, et al. A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 2533–2533.

Lyerly, H. K., et al. “A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.” Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2011, pp. 2533–2533. Crossref, doi:10.1200/jco.2011.29.15_suppl.2533.

Lyerly HK, Hobeika A, Niedzwiecki D, Osada T, Marshall J, Garrett CR, Chang DZ, Aklilu M, Crocenzi TS, Cole DJ, Dessureault S, Hsu SD, Bulusu A, Clary BM, Annechiarico R, Devi G, Chadaram V, Clay TM, Morse M. A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 2533–2533.